SAFESCIENCE INC
10-K/A, EX-27, 2000-06-20
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SAFESCIENCE INC, 10-K/A, EX-23.1, 2000-06-20
Next: SAFESCIENCE INC, S-3/A, 2000-06-20



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Consolidated  Statement of Financial  Condition at December 31, 1999 Audited and
the  Consolidated  Statement of Income for the twelve months ended  December 31,
1998 Audited and is  qualified  in its  entirety by reference to such  financial
statements.
</LEGEND>

<S>                                                           <C>
<PERIOD-TYPE>                                                 YEAR
<FISCAL-YEAR-END>                                             DEC-31-1999
<PERIOD-END>                                                  DEC-31-1999
<CASH>                                                        3,377,067
<SECURITIES>                                                          0
<RECEIVABLES>                                                    95,222
<ALLOWANCES>                                                     43,000
<INVENTORY>                                                     356,211
<CURRENT-ASSETS>                                              4,367,323
<PP&E>                                                          519,721
<DEPRECIATION>                                                  125,563
<TOTAL-ASSETS>                                                5,670,245
<CURRENT-LIABILITIES>                                         1,149,129
<BONDS>                                                               0
                                                 0
                                                           0
<COMMON>                                                        168,359
<OTHER-SE>                                                    4,352,758
<TOTAL-LIABILITY-AND-EQUITY>                                  5,670,245
<SALES>                                                       1,368,513
<TOTAL-REVENUES>                                              1,722,005
<CGS>                                                         1,410,731
<TOTAL-COSTS>                                                 1,410,731
<OTHER-EXPENSES>                                             12,604,929
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                   28
<INCOME-PRETAX>                                             (12,301,718)
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                                   0
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                (12,301,718)
<EPS-BASIC>                                                        (.77)
<EPS-DILUTED>                                                      (.77)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission